Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-17

Clinical Trial Update: Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AYX1 for safety and efficacy in reducing pain after knee replacement surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AYX1 Injection (AYX1)

Snippet

Sponsor: Adynxx, Inc. | Conditions: Post-surgical Pain | Phase 2 | Status: COMPLETED